These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 36105805)
1. The collectin SP-A and its trimeric recombinant fragment protect alveolar epithelial cells from the cytotoxic and proinflammatory effects of human cathelicidin de Tapia L; García-Fojeda B; Kronqvist N; Johansson J; Casals C Front Immunol; 2022; 13():994328. PubMed ID: 36105805 [TBL] [Abstract][Full Text] [Related]
2. Cooperative action of SP-A and its trimeric recombinant fragment with polymyxins against Gram-negative respiratory bacteria. Coya JM; Fraile-Ágreda V; de Tapia L; García-Fojeda B; Sáenz A; Bengoechea JA; Kronqvist N; Johansson J; Casals C Front Immunol; 2022; 13():927017. PubMed ID: 36159837 [TBL] [Abstract][Full Text] [Related]
3. Peptidylarginine deiminases present in the airways during tobacco smoking and inflammation can citrullinate the host defense peptide LL-37, resulting in altered activities. Kilsgård O; Andersson P; Malmsten M; Nordin SL; Linge HM; Eliasson M; Sörenson E; Erjefält JS; Bylund J; Olin AI; Sørensen OE; Egesten A Am J Respir Cell Mol Biol; 2012 Feb; 46(2):240-8. PubMed ID: 21960546 [TBL] [Abstract][Full Text] [Related]
4. Antibacterial function of the human cathelicidin-18 peptide (LL-37) between theory and practice. Iacob SA; Iacob DG Protein Pept Lett; 2014; 21(12):1247-56. PubMed ID: 25101632 [TBL] [Abstract][Full Text] [Related]
5. Cathelicidin is a "fire alarm", generating protective NLRP3-dependent airway epithelial cell inflammatory responses during infection with Pseudomonas aeruginosa. McHugh BJ; Wang R; Li HN; Beaumont PE; Kells R; Stevens H; Young L; Rossi AG; Gray RD; Dorin JR; Gwyer Findlay EL; Brough D; Davidson DJ PLoS Pathog; 2019 Apr; 15(4):e1007694. PubMed ID: 30978238 [TBL] [Abstract][Full Text] [Related]
6. High-quality 3D structures shine light on antibacterial, anti-biofilm and antiviral activities of human cathelicidin LL-37 and its fragments. Wang G; Mishra B; Epand RF; Epand RM Biochim Biophys Acta; 2014 Sep; 1838(9):2160-72. PubMed ID: 24463069 [TBL] [Abstract][Full Text] [Related]
7. Augmentation of the bactericidal activities of human cathelicidin CAP18/LL-37-derived antimicrobial peptides by amino acid substitutions. Nagaoka I; Kuwahara-Arai K; Tamura H; Hiramatsu K; Hirata M Inflamm Res; 2005 Feb; 54(2):66-73. PubMed ID: 15750713 [TBL] [Abstract][Full Text] [Related]
8. Antibacterial effect of human mesenchymal stem cells is mediated in part from secretion of the antimicrobial peptide LL-37. Krasnodembskaya A; Song Y; Fang X; Gupta N; Serikov V; Lee JW; Matthay MA Stem Cells; 2010 Dec; 28(12):2229-38. PubMed ID: 20945332 [TBL] [Abstract][Full Text] [Related]
9. Cathelicidin LL-37 increases lung epithelial cell stiffness, decreases transepithelial permeability, and prevents epithelial invasion by Pseudomonas aeruginosa. Byfield FJ; Kowalski M; Cruz K; Leszczyńska K; Namiot A; Savage PB; Bucki R; Janmey PA J Immunol; 2011 Dec; 187(12):6402-9. PubMed ID: 22095714 [TBL] [Abstract][Full Text] [Related]
10. The human cathelicidin LL-37 preferentially promotes apoptosis of infected airway epithelium. Barlow PG; Beaumont PE; Cosseau C; Mackellar A; Wilkinson TS; Hancock RE; Haslett C; Govan JR; Simpson AJ; Davidson DJ Am J Respir Cell Mol Biol; 2010 Dec; 43(6):692-702. PubMed ID: 20097832 [TBL] [Abstract][Full Text] [Related]
11. Augmentation of the lipopolysaccharide-neutralizing activities of human cathelicidin CAP18/LL-37-derived antimicrobial peptides by replacement with hydrophobic and cationic amino acid residues. Nagaoka I; Hirota S; Niyonsaba F; Hirata M; Adachi Y; Tamura H; Tanaka S; Heumann D Clin Diagn Lab Immunol; 2002 Sep; 9(5):972-82. PubMed ID: 12204946 [TBL] [Abstract][Full Text] [Related]
12. Cathelicidin antimicrobial peptide from Alligator mississippiensis has antibacterial activity against multi-drug resistant Acinetobacter baumanii and Klebsiella pneumoniae. Barksdale SM; Hrifko EJ; van Hoek ML Dev Comp Immunol; 2017 May; 70():135-144. PubMed ID: 28089718 [TBL] [Abstract][Full Text] [Related]
13. Short-Term versus Long-Term Culture of A549 Cells for Evaluating the Effects of Lipopolysaccharide on Oxidative Stress, Surfactant Proteins and Cathelicidin LL-37. Nova Z; Skovierova H; Strnadel J; Halasova E; Calkovska A Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32050475 [TBL] [Abstract][Full Text] [Related]
14. Antimicrobial and chemoattractant activity, lipopolysaccharide neutralization, cytotoxicity, and inhibition by serum of analogs of human cathelicidin LL-37. Ciornei CD; Sigurdardóttir T; Schmidtchen A; Bodelsson M Antimicrob Agents Chemother; 2005 Jul; 49(7):2845-50. PubMed ID: 15980359 [TBL] [Abstract][Full Text] [Related]
15. The human cathelicidin LL-37 inhibits influenza A viruses through a mechanism distinct from that of surfactant protein D or defensins. Tripathi S; Tecle T; Verma A; Crouch E; White M; Hartshorn KL J Gen Virol; 2013 Jan; 94(Pt 1):40-49. PubMed ID: 23052388 [TBL] [Abstract][Full Text] [Related]
16. Cathelicidin host defence peptide augments clearance of pulmonary Pseudomonas aeruginosa infection by its influence on neutrophil function in vivo. Beaumont PE; McHugh B; Gwyer Findlay E; Mackellar A; Mackenzie KJ; Gallo RL; Govan JR; Simpson AJ; Davidson DJ PLoS One; 2014; 9(6):e99029. PubMed ID: 24887410 [TBL] [Abstract][Full Text] [Related]
17. Multifunctional roles of human cathelicidin (LL-37) at the ocular surface. Huang LC; Petkova TD; Reins RY; Proske RJ; McDermott AM Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2369-80. PubMed ID: 16723446 [TBL] [Abstract][Full Text] [Related]